Aprea Therapeutics, Inc (APRE) Stock Price

1.21 ▲ +0.02 (+1.68%)
Open: 1.18 Vol: 41.75K Day's range: 1.1528 - 1.24 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
APRE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.24▼ 1.21▲ 1.21▲ 1.25▼ 1.36▼
MA10 1.21▲ 1.22▼ 1.23▼ 1.28▼ 1.42▼
MA20 1.22▼ 1.24▼ 1.25▼ 1.37▼ 1.55▼
MA50 1.25▼ 1.26▼ 1.29▼ 1.44▼ 2.15▼
MA100 1.27▼ 1.34▼ 1.38▼ 1.57▼ 3.38▼
MA200 1.33▼ 1.43▼ 1.43▼ 1.86▼ 8.18▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.005▲ 0.000▲ 0.001▲ -0.015▼ 0.010▲
RSI 46.757▼ 44.775▼ 43.940▼ 37.004▼ 33.144▼
STOCH 65.000     37.652     34.387     23.773     19.359▼
WILL %R -50.000     -56.522     -56.522     -83.037▼ -91.068▼
CCI 17.726     -36.619     -46.315     -102.094▼ -184.826▼
Latest Filters Detected On APRE
▼ GAP $APRE Open Gap Down %2 Set Alert
Aprea Therapeutics, Inc News
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
Wednesday, November 12, 2025 05:48 AM
In ongoing Phase 1 ACESOT-1051dose-escalation trial, 3 out of 4 patients at Dose Level 6 (100 mg once daily) achieved stable disease, per RECIST v1.1, in heavily pretreated gastrointestinal and ...
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
Friday, October 24, 2025 05:31 AM
DOYLESTOWN, Pa., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that ...
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
Tuesday, October 14, 2025 01:00 AM
DOYLESTOWN, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that ...
APRE historical stock data
date open high low close volume
14/11/25 1.18 1.24 1.1528 1.21 41,751
13/11/25 1.23 1.245 1.17 1.19 607,912
12/11/25 1.28 1.29 1.2302 1.26 29,574
11/11/25 1.27 1.32 1.27 1.32 18,838
10/11/25 1.24 1.27 1.21 1.27 29,125
07/11/25 1.23 1.29 1.2201 1.23 36,246
06/11/25 1.31 1.33 1.19 1.20 44,406
05/11/25 1.36 1.38 1.31 1.312 73,911
04/11/25 1.36 1.40 1.36 1.37 39,876
03/11/25 1.40 1.45 1.39 1.40 51,457
Quote Details
52wk Low:1.153
52wk High:5.00
Vol:41.75K
Avg Vol(3m):1.6M
1Y Chng:-58.28%
1M Chng:-18.52%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.93M